Breast Cancer

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

Arthritis
Arthritis
FDA: New Option for Psoriatic Arthritis Approved
12/15/2017
The US Food and Drug Administration recently approved a drug for the treatment of adults with active psoriatic arthritis.
12/15/2017
Arthritis
Arthritis
FDA: New Option for Psoriatic Arthritis Approved
12/15/2017
The US Food and Drug Administration recently approved a drug for the treatment of adults with active psoriatic arthritis.
12/15/2017
Arthritis
Arthritis
FDA: New Option for Psoriatic Arthritis Approved
12/15/2017
The US Food and Drug Administration recently approved a drug for the treatment of adults with active psoriatic arthritis.
12/15/2017
FDA
FDA
FDA: Biosimilar To RA Drug Approved
12/14/2017
The US Food and Drug Administration recently approved a biosimilar to a drug used for the treatment of various autoimmune diseases, including rheumatoid arthritis and Crohn disease.
12/14/2017
FDA
FDA
FDA: Biosimilar To RA Drug Approved
12/14/2017
The US Food and Drug Administration recently approved a biosimilar to a drug used for the treatment of various autoimmune diseases, including rheumatoid arthritis and Crohn disease.
12/14/2017
FDA
FDA
FDA: Biosimilar To RA Drug Approved
12/14/2017
The US Food and Drug Administration recently approved a biosimilar to a drug used for the treatment of various autoimmune diseases, including rheumatoid arthritis and Crohn disease.
12/14/2017
Autoimmune diseases
Autoimmune diseases
FDA Approves First Treatment for Rare Autoimmune disease
12/12/2017
The US Food and Drug Administration has recently approved the first treatment option for patients with eosinophilic granulomatosis with polyangiitis.
12/12/2017
Autoimmune diseases
Autoimmune diseases
FDA Approves First Treatment for Rare Autoimmune disease
12/12/2017
The US Food and Drug Administration has recently approved the first treatment option for patients with eosinophilic granulomatosis with polyangiitis.
12/12/2017
Autoimmune diseases
Autoimmune diseases
FDA Approves First Treatment for Rare Autoimmune disease
12/12/2017
The US Food and Drug Administration has recently approved the first treatment option for patients with eosinophilic granulomatosis with polyangiitis.
12/12/2017
COPD
COPD
FDA Approves New Option for COPD
12/06/2017
The FDA has approved a new option for the long-term maintenance treatment of airflow obstruction in individuals with chronic obstructive pulmonary disease.
12/06/2017